[1]Einhorn TA, Lee CA.Bone regeneration: new findings and potential clinical applications.J Am Acad Orthop Surg. 2001; 9(3):157-165.
[2]Segar CE, Ogle ME, Botchwey EA.Regulation of angiogenesis and bone regeneration with natural and synthetic small molecules.Curr Pharm Des. 2013;19(19): 3403-3419.
[3]Keramaris NC, Calori GM, Nikolaou VS,et al.Fracture vascularity and bone healing: a systematic review of the role of VEGF.Injury. 2008;39 Suppl 2:S45-57.
[4]Yoo CH, Na HJ, Lee DS,et al.Endothelial progenitor cells from human dental pulp-derived iPS cells as a therapeutic target for ischemic vascular diseases.Biomaterials. 2013;34(33): 8149-8160.
[5]Zhang S, Ma X, Yao K,et al.Combination of CD34-positive cell subsets with infarcted myocardium-like matrix stiffness: a potential solution to cell-based cardiac repair.J Cell Mol Med. 2014;18(6):1236-1238.
[6]Doyle B, Metharom P, Caplice NM.Endothelial progenitor cells.Endothelium. 2006;13(6):403-410.
[7]Asahara T, Murohara T, Sullivan A,et al.Isolation of putative progenitor endothelial cells for angiogenesis.Science. 1997; 275(5302):964-967.
[8]Li T, Ma Q, Ning M,et al.Cotransplantation of human umbilical cord-derived mesenchymal stem cells and umbilical cord blood-derived CD34? cells in a rabbit model of myocardial infarction.Mol Cell Biochem. 2014;387(1-2):91-100.
[9]Zhang S, An Q, Li Q,et al.Therapeutic benefit of bone marrow-derived endothelial progenitor cell transplantation after experimental aneurysm embolization with coil in rats. PLoS One. 2014;9(2):e90069.
[10]Kanzler I, Tuchscheerer N, Steffens G,et al.Differential roles of angiogenic chemokines in endothelial progenitor cell-induced angiogenesis.Basic Res Cardiol. 2013;108(1): 310.
[11]Haller A.Experimentorum de ossiem formatione. Opera Minora.1763;2:400.
[12]Carano RA, Filvaroff EH.Angiogenesis and bone repair.Drug Discov Today. 2003;8(21):980-989.
[13]Glowacki J.Angiogenesis in fracture repair.Clin Orthop Relat Res. 1998;(355 Suppl):S82-89.
[14]Hankenson KD, Dishowitz M, Gray C, et al.Angiogenesis in bone regeneration.Injury. 2011;42(6):556-561.
[15]Yamagiwa H, Endo N.Bone fracture and the healing mechanisms. Histological aspect of fracture healing. Primary and secondary healing.Clin Calcium. 2009;19(5):627-633.
[16]Dickson KF, Katzman S, Paiement G.The importance of the blood supply in the healing of tibial fractures.Contemp Orthop. 1995;30(6):489-493.
[17]Risau W, Flamme I.Vasculogenesis.Annu Rev Cell Dev Biol. 1995;11:73-91.
[18]Risau W.Mechanisms of angiogenesis.Nature. 1997;386 (6626): 671-674.
[19]George AL, Bangalore-Prakash P, Rajoria S,et al.Endothelial progenitor cell biology in disease and tissue regeneration.J Hematol Oncol. 2011;4:24.
[20]Alev C, Ii M, Asahara T.Endothelial progenitor cells: a novel tool for the therapy of ischemic diseases.Antioxid Redox Signal. 2011;15(4):949-965.
[21]Reyes M, Dudek A, Jahagirdar B, et al.Origin of endothelial progenitors in human postnatal bone marrow.J Clin Invest. 2002;109(3):337-346.
[22]Urbich C, Dimmeler S.Endothelial progenitor cells: characterization and role in vascular biology.Circ Res. 2004; 95(4):343-353.
[23]Gehling UM, Ergün S, Schumacher U,et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells.Blood. 2000;95(10):3106-3112.
[24]Yoder MC, Ingram DA.Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system.Curr Opin Hematol. 2009;16(4):269-273.
[25]Tei K, Matsumoto T, Mifune Y,et al.Administrations of peripheral blood CD34-positive cells contribute to medial collateral ligament healing via vasculogenesis.Stem Cells. 2008;26(3):819-830.
[26]Bompais H, Chagraoui J, Canron X,et al.Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells.Blood. 2004;103(7):2577-2584.
[27]Mund JA, Ingram DA, Yoder MC,et al.Endothelial progenitor cells and cardiovascular cell-based therapies.Cytotherapy. 2009;11(2):103-113.
[28]Lassaletta AD, Elmadhun NY, Burgess TA,et al.Microvascular notch signaling is upregulated in response to vascular endothelial growth factor and chronic myocardial ischemia.Circ J. 2014;78(3):743-751.
[29]Morancho A, Hernández-Guillamon M, Boada C,et al.Cerebral ischaemia and matrix metalloproteinase-9 modulate the angiogenic function of early and late outgrowth endothelial progenitor cells.J Cell Mol Med. 2013;17(12): 1543-1553.
[30]Geiger F, Bertram H, Berger I,et al.Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects.J Bone Miner Res. 2005;20(11):2028-2035.
[31]Holstein JH, Menger MD, Scheuer C,et al.Erythropoietin (EPO): EPO-receptor signaling improves early endochondral ossification and mechanical strength in fracture healing.Life Sci. 2007;80(10):893-900.
[32]Li R, Stewart DJ, von Schroeder HP,et al.Effect of cell-based VEGF gene therapy on healing of a segmental bone defect.J Orthop Res. 2009;27(1):8-14.
[33]Segal MS, Sautina L, Li S,et al.Relaxin increases human endothelial progenitor cell NO and migration and vasculogenesis in mice.Blood. 2012;119(2):629-636.
[34]Huang PH, Chen YH, Wang CH,et al.Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells.Arterioscler Thromb Vasc Biol. 2009;29(8):1179-1184.
[35]Li R, Nauth A, Li C,et al.Expression of VEGF gene isoforms in a rat segmental bone defect model treated with EPCs.J Orthop Trauma. 2012;26(12):689-692.
[36]Sanchis-Gomar F, Garcia-Gimenez JL, Pareja-Galeano H,et al.Erythropoietin and the heart: physiological effects and the therapeutic perspective.Int J Cardiol. 2014;171(2):116-125.
[37]Ma XL, Sun XL, Wan CY,et al.Significance of circulating endothelial progenitor cells in patients with fracture healing process.J Orthop Res. 2012;30(11):1860-1866.
[38]Li R, Atesok K, Nauth A,et al.Endothelial progenitor cells for fracture healing: a microcomputed tomography and biomechanical analysis.J Orthop Trauma. 2011;25(8):467- 471.
[39]Lee DY, Cho TJ, Kim JA,et al.Mobilization of endothelial progenitor cells in fracture healing and distraction osteogenesis. Bone. 2008;42(5):932-941.
[40]Sun S, Liu Z, Zhou H,et al.The role of fucosylation in the promotion of endothelial progenitor cells in neovascularization and bone repair.Biomaterials. 2014;35(12):3777-3785.
[41]Zarbock A, Ley K, McEver RP,et al.Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow.Blood. 2011;118(26): 6743-6751.
[42]Kuroda R, Matsumoto T, Miwa M,et al.Local transplantation of G-CSF-mobilized CD34(+) cells in a patient with tibial nonunion: a case report.Cell Transplant. 2011;20(9): 1491- 1496.
[43]Fukui T, Mifune Y, Matsumoto T,et al.Superior Potential of CD34-Positive Cells Compared to Total Mononuclear Cells for Healing of Nonunion Following Bone Fracture.Cell Transplant. 2014 May 2. [Epub ahead of print]
[44]Li R, Nauth A, Gandhi R,et al.BMP-2 mRNA expression after endothelial progenitor cell therapy for fracture healing.J Orthop Trauma. 2014;28 Suppl 1:S24-27.
[45]Kaigler D, Krebsbach PH, West ER, et al.Endothelial cell modulation of bone marrow stromal cell osteogenic potential. FASEB J. 2005;19(6):665-667.
[46]Raida M, Heymann AC, Günther C,et al.Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells.Int J Mol Med. 2006;18(4):735-739.
[47]Fedorovich NE, Haverslag RT, Dhert WJ,et al.The role of endothelial progenitor cells in prevascularized bone tissue engineering: development of heterogeneous constructs. Tissue Eng Part A. 2010;16(7):2355-2367.
[48]Aguirre A, Planell JA, Engel E.Dynamics of bone marrow-derived endothelial progenitor cell/mesenchymal stem cell interaction in co-culture and its implications in angiogenesis.Biochem Biophys Res Commun. 2010;400(2): 284-291. |